Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroup

Autor: Stellwagen, John C.1 john.stellwagen@amgen.com, Adjabeng, George M.1, Arnone, Marc R.2, Dickerson, Scott H.1, Han, Chao2, Hornberger, Keith R.2, King, Alastair J.2, Mook, Robert A.1, Petrov, Kimberly G.1, Rheault, Tara R.1, Rominger, Cynthia M.2, Rossanese, Olivia W.2, Smitheman, Kimberly N.2, Waterson, Alex G.1, Uehling, David E.1 david.uehling@oicr.on.ca
Zdroj: Bioorganic & Medicinal Chemistry Letters. Aug2011, Vol. 21 Issue 15, p4436-4440. 5p.
Databáze: Academic Search Ultimate